Restriction of LABA use to combination ICS/LABA inhaler therapy in asthma

被引:7
|
作者
Beasley, Richard [1 ,2 ]
Fingleton, James [1 ,2 ]
Weatherall, Mark [2 ,3 ]
机构
[1] Med Res Inst New Zealand, Dept Internal Med, Wellington 6242, New Zealand
[2] Capital & Coast Dist Hlth Board, Dept Internal Med, Wellington, New Zealand
[3] Univ Otago Wellington, Dept Med, Wellington, New Zealand
关键词
RANDOMIZED CONTROLLED-TRIALS; FLUTICASONE PROPIONATE; EXTERNAL VALIDITY; SALMETEROL; CORTICOSTEROIDS; ADHERENCE; ADULTS; RISK; METAANALYSIS; MORTALITY;
D O I
10.1136/thoraxjnl-2012-202483
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
引用
收藏
页码:119 / 120
页数:2
相关论文
共 50 条
  • [31] LABA/LAMA versus LABA/ICS fixed-dose combinations in the prevention of COPD exacerbations: a modeling analysis of literature aggregate data
    Gong, Yiwen
    Sui, Zichao
    Lv, Yinghua
    Zheng, Qingshan
    Li, Lujin
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 79 (10) : 1321 - 1332
  • [32] Effectiveness and Safety of COPD Maintenance Therapy with Tiotropium/Olodaterol versus LABA/ICS in a US Claims Database
    Jennifer K. Quint
    Jukka Montonen
    Daina B. Esposito
    Xintong He
    Leslie Koerner
    Laura Wallace
    Alberto de la Hoz
    Marc Miravitlles
    Advances in Therapy, 2021, 38 : 2249 - 2270
  • [33] A Comparison of the Real-Life Clinical Effectiveness of the Leading Licensed ICS/LABA Combination Inhalers in the Treatment for COPD
    Ming, Simon Wan Yau
    Haughney, John
    Ryan, Dermot
    Small, Iain
    Lavorini, Federico
    Papi, Alberto
    Singh, Dave
    Halpin, David M. G.
    Hurst, John R.
    Patel, Shishir
    Ochel, Matthias
    Kocks, Janwillem
    Carter, Victoria
    Hardjojo, Antony
    Price, David B.
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2020, 15 : 3093 - 3103
  • [34] Effects of LAMA/LABA Alone and in Combination on Cardiac Safety
    Andreas, Stefan
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2020, 15 : 1931 - 1933
  • [35] Outcomes of Patients with COPD Treated with ICS/LABA Before and After Initiation of Single-Inhaler Triple Therapy with Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI)
    Mccormack, Meredith
    Paczkowski, Rosirene
    Gronroos, Noelle N.
    Noorduyn, Stephen G.
    Lee, Lydia
    Veeranki, Phani
    Johnson, Mary G.
    Igboekwe, Emmeline
    Kahle-Wrobleski, Kristin
    Panettieri, Reynold
    ADVANCES IN THERAPY, 2024, 41 (03) : 1245 - 1261
  • [36] Stopping long-acting beta2-agonists (LABA) for adults with asthma well controlled by LABA and inhaled corticosteroids
    Ahmad, Shaleen
    Kew, Kayleigh M.
    Normansell, Rebecca
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2015, (06):
  • [37] Loss of bronchoprotection with ICS plus LABA treatment, β-receptor dynamics, and the effect of alendronate
    Cardet, Juan Carlos
    Jiang, Xiaofeng
    Lu, Quan
    Gerard, Norma
    McIntire, Kristen
    Boushey, Homer A.
    Castro, Mario
    Chinchilli, Vernon M.
    Codispoti, Christopher D.
    Dyer, Anne-Marie
    Holguin, Fernando
    Kraft, Monica
    Lazarus, Stephen
    Lemanske, Robert F.
    Lugogo, Njira
    Mauger, Dave
    Moore, Wendy C.
    Moy, James
    Ortega, Victor E.
    Peters, Stephen P.
    Smith, Lewis J.
    Solway, Julian
    Sorkness, Christine A.
    Sumino, Kaharu
    Wechsler, Michael E.
    Wenzel, Sally
    Israel, Elliot
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 144 (02) : 416 - +
  • [38] Predictors of ICS/LABA prescribing in COPD patients: a study from general practice
    Elin Drivenes
    Anders Østrem
    Hasse Melbye
    BMC Family Practice, 15
  • [39] Stopping long-acting beta2-agonists (LABA) for children with asthma well controlled on LABA and inhaled corticosteroids
    Kew, Kayleigh M.
    Beggs, Sean
    Ahmad, Shaleen
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2015, (05):
  • [40] Predictors of ICS/LABA prescribing in COPD patients: a study from general practice
    Drivenes, Elin
    Ostrem, Anders
    Melbye, Hasse
    BMC FAMILY PRACTICE, 2014, 15